Science & Enterprise subscription

Follow us on Twitter

  • A company developing a system with artificial intelligence to analyze medical literature for treatment insights is… https://t.co/TdK2vtumZo
    about 11 hours ago
  • New post on Science and Enterprise: Medical Knowledge A.I. Company Raises Early $4.8M https://t.co/lqYHuWQs7g #Science #Business
    about 11 hours ago
  • New contributed post on Science and Enterprise: https://t.co/3Gofb2uiDv Guidelines for Training New Employees
    about 14 hours ago
  • Regenstrief Institute, affiliated with Indiana University, is investing in a new company aiming to improve long-ter… https://t.co/87KTKEoWp8
    about 15 hours ago
  • New post on Science and Enterprise: Institute Invests in Elderly Care Start-Up https://t.co/mCNnAqV9yY #Science #Business
    about 15 hours ago

Please share Science & Enterprise

FDA – New Processes, Incentives Needed for Drug Shortages

Pills and dollar bill

A report from the Food and Drug Administration identifies the causes of recent shortages of some drugs, and calls for new processes and incentives to prevent future shortages. . . . → Read More: FDA – New Processes, Incentives Needed for Drug Shortages

MD Anderson, Biotech Partner on T-Cell Receptors

T lymphocyte

A cancer center and biotechnology company are creating treatments that target proteins on immune-system cells unique to each patient. . . . → Read More: MD Anderson, Biotech Partner on T-Cell Receptors

Trial Shows Nanotech Drug Induces Gluten Tolerance

bread and rolls

Results from a clinical trial show an experimental treatment encourages immune-system tolerance of gluten, preventing intestinal damage from celiac disease. . . . → Read More: Trial Shows Nanotech Drug Induces Gluten Tolerance

Implanted Overdose Rescue Device Being Developed

Overdose rescue device

An implanted device that senses an overdose of opioid drugs and dispenses an emergency rescue medicine is in development by two university labs. . . . → Read More: Implanted Overdose Rescue Device Being Developed

Early Results Show Anti-Depressive Drug Effects

Man with depression

Initial results from a clinical trial show a drug designed to supplement first-line treatments helps reduce symptoms of major depressive disorder. . . . → Read More: Early Results Show Anti-Depressive Drug Effects

Real-World Evidence Assessed for Cancer Drug Trials

Assorted medical tools

Two medical technology companies are evaluating real-world evidence from patients to simulate randomized clinical trials for testing new cancer treatments. . . . → Read More: Real-World Evidence Assessed for Cancer Drug Trials

Trial to Test CBD for Parkinson’s-Related Psychosis

Cannabis plant

A clinical trial is planned to test cannabidiol, or CBD, derived from cannabis as a treatment for hallucinations and delusions among people with Parkinson’s disease. . . . → Read More: Trial to Test CBD for Parkinson’s-Related Psychosis

Nanoparticles Designed to Cross Blood-Brain Barrier

Neurons

Nanoscale particles derived from viruses are shown in tests with lab mice to cross the blood-brain barrier, and reach nerve cells in the brain. . . . → Read More: Nanoparticles Designed to Cross Blood-Brain Barrier

Companies Developing Hemophilia Gene Editing Therapy

Mountain bluebird

A partnership between drug maker Novo Nordisk and biotechnology company bluebird bio is designing a treatment for hemophilia with gene-editing proteins. . . . → Read More: Companies Developing Hemophilia Gene Editing Therapy

Merck Gaining Gut Microbe Technology for Vaccines

Microbiome graphic

Drug maker Merck & Co. is partnering with a developer of treatments for disease derived from microbes in the gut, for discovery of up to three vaccines. . . . → Read More: Merck Gaining Gut Microbe Technology for Vaccines